Real world treatment patterns and healthcare resource utilization (HRU) among chronic lymphocytic leukemia (CLL) patients by regimen.

被引:0
|
作者
Byfield, Stacey DaCosta
Korrer, Stephanie
Ellis, Lorie
Schenkel, Brad
机构
[1] OptumInsight, Eden Prairie, MN USA
[2] Optum, Eden Prairie, MN USA
[3] Janssen Sci Affairs LLC, Horsham, PA USA
关键词
D O I
10.1200/jco.2015.33.15_suppl.e18043
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
e18043
引用
收藏
页数:1
相关论文
共 50 条
  • [1] Real-world treatment patterns and health care resource utilization (HRU) among patients with chronic lymphocytic leukemia (CLL) by regimen
    Schenkel, Brad
    Ellis, Lorie
    Korrer, Stephanie
    Byfield, Stacey DaCosta
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (07)
  • [2] Real world treatment patterns, adverse events and healthcare resource utilization and costs among chronic lymphocytic leukemia (CLL) patients in the US
    Kabadi, Shaum
    Olufade, Temitope O.
    Le, Lisa
    Byfield, Stacey Dacosta
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2019, 28 : 78 - 79
  • [3] Real-world healthcare resource utilization (HRU)/costs associated with venetoclax treatment among chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL) patients.
    Rogers, Kerry Anne
    Emond, Bruno
    Manceur, Ameur M.
    Kinkead, Frederic
    Lafeuille, Marie-Helene
    Lefebvre, Patrick
    Huang, Qing
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [4] Real World Treatment Patterns, Adverse Events and Healthcare Resource Utilization and Costs Among Chronic Lymphocytic Leukemia (CLL) Patients in the United States
    Kabadi, Shaum
    Le, Lisa
    Byfield, Stacey Dacosta
    Olufade, Temitope O.
    [J]. BLOOD, 2018, 132
  • [5] Healthcare Resource Utilization (HRU) in Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia
    Kozma, Chris
    Slaton, Terra
    McKenzie, Scott
    Ellis, Lone
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2014, 14 : S132 - S132
  • [6] Real-World Treatment Patterns, Adherence and Healthcare Resource Utilization for Chronic Lymphocytic Leukemia/Small Lymphocytic Leukemia Among Veterans in the United States
    Yang, Keri
    Liu, Sizhu
    Tang, Boxiong
    Chanan-Khan, Asher
    [J]. BLOOD, 2021, 138
  • [7] EFFECT OF EARLIER USE OF IBRUTINIB ON HEALTHCARE RESOURCE UTILIZATION (HRU) AND COSTS AMONG PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) OR SMALL LYMPHOCYTIC LYMPHOMA (SLL) IN THE UNITED STATES
    Challagulla, S.
    Lee, P.
    Giafis, N.
    Manceur, A. M.
    Fakih, I
    Emond, B.
    Iyengar, R.
    [J]. VALUE IN HEALTH, 2021, 24 : S37 - S37
  • [8] HEALTHCARE RESOURCE UTILIZATION AMONG PATIENTS RECEIVING TREATMENT FOR CHRONIC LYMPHOCYTIC LEUKEMIA: REAL-WORLD DATA FROM A LARGE HEALTHCARE PROVIDER
    Weil, C.
    Chodick, G.
    Shalev, V
    Kan, I
    Afik, R.
    Cohen, R.
    Sail, K.
    [J]. VALUE IN HEALTH, 2019, 22 : S412 - S413
  • [9] Real-World Evaluation of Treatment Discontinuation and Healthcare Resource Utilization in Patients with Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
    Chanan-Khan, Asher Alban
    Challagulla, Swetha
    Donckels, Elizabeth
    Chuang, Po-Ya
    Yang, Keri
    [J]. BLOOD, 2023, 142
  • [10] Understanding real world treatment patterns, healthcare resource utilization (HRU) and costs among metastatic renal cell carcinoma (mRCC) patients
    Copher, R.
    Byfield, S. Dacosta
    Buzinec, P.
    Korrer, S.
    Baig, M.
    [J]. ANNALS OF ONCOLOGY, 2016, 27